The aim of this study was to investigate the high level of pulmonary Mycobacterium abscessus infections and implement a surveillance programme among 43 ventilator-dependent patients, 15 with pulmonary M. abscessus infections, in a hospital long-term respiratory care ward (RCW) in central Taiwan. M. abscessus isolates were obtained from 35 patients in the RCW of hospital A, 6 patients in the RCWs of another three hospitals (B, C and D), and from 4 water sources in two of the hospitals (A and B). Strains were characterized by methods including hsp65 PCR-RFLP and PFGE. The patients were followed-up by chest X-ray for 1 year. All clinical isolates were type I and II, and belonged to ten distinct clusters of PFGE patterns. Five clinical strains in two hospitals belonged to a single cluster, whilst four clinical strains in the other two hospitals belonged to a single unique cluster. The strains from hospital A fell into nine clusters and were distinct from the strains isolated from the water supply. Patients infected with type I strains showed a significantly more rapid progression of disease. The number of different strains involved suggested either that there had been a polyclonal outbreak or that a high level of endemic infections was present in the RCW of hospital A. This and the lack of homology between the clinical and environmental isolates from hospital A raised the possibility that pulmonary M. abscessus infections may have been spread by the movement of patients between RCWs, a routine practice in Taiwan's integrated delivery system.
INTRODUCTION
Reports of nosocomial outbreaks of non-tuberculous mycobacteria (NTM), many of which have been linked to contaminated hospital water systems (Wallace et al., 1998) , have been increasing (Phillips & von Reyn, 2001 ). Mycobacterium abscessus is a rapidly growing NTM species that can cause a variety of conditions ranging from infection of surgical wounds to chronic pulmonary disease (Fox et al., 2004; Koh et al., 2002; Phillips & von Reyn, 2001; Scholze et al., 2005) . Although patients with chronic lung diseases are known to be more susceptible to infection by M. abscessus, few outbreaks have been reported among patients with chronic ventilator dependency in respiratory care wards (RCWs).
In March 2004 , a patient in the RCW of hospital A developed a productive cough and a persistent fever. Sputum specimens from this patient and the two patients in adjacent beds yielded M. abscessus. To determine the extent and source of these infections, and establish a surveillance programme, we performed molecular typing of clinical isolates from the 38 patients in the ward, from 5 patients who were admitted to the ward after the beginning of the study, and from patients of 3 other hospitals within our integrated delivery system (IDS) that also had apparent outbreaks. We also analysed specimens of the tap water and from a drinking water machine from two of the hospitals. Patients were considered to have M. abscessus pulmonary disease if they met the American Thoracic Society (ATS) criteria for NTM pulmonary disease (Griffith et al., 2007) . Briefly, the patients had to be symptomatic, have abnormalities visible on chest radiography or high-resolution computed tomography, and fulfil at least one of the following three microbiological criteria: positive culture results for M. abscessus from at least two sputum specimens; positive culture results for M. abscessus from at least one bronchial wash or lavage specimen; or acid-fast bacilli (AFB) or granulomas and positive cultures for M. abscessus from lung histopathological specimens or at least one sputum sample or bronchial washing that was culture positive for M. abscessus.
METHODS
Demographic and clinical information, such as age, sex, clinical symptoms/signs, chest radiographs, and the presence of co-morbidities, were collected from the patients' medical records. None of the initial and newly admitted patients had open wounds or surgical sites. During the 12 month follow-up period after May 2004, chest radiography was performed every 3 months, the films were examined and any deaths were recorded. Serial changes in the chest radiographs were graded as 'no change', 'improved' or 'progressed'. The study was reviewed and approved by the institutional review board of Taichung Veterans General Hospital.
Clinical mycobacterial isolates. Three or four transbronchial aspirates were collected from each of the 38 initial patients and the 5 newly admitted patients in the RCW of hospital A. Acid-fast staining and mycobacterial culturing were performed on each of the aspirate specimens as follows. Transbronchial aspirates were digested using a standard N-acetyl-L-cysteine/NaOH technique (Thornton et al., 1998) . The digests were streaked onto Lowenstein-Jensen (L-J) slants, incubated at 37 uC with 5 % CO 2 and inoculated into BACTEC MGIT tubes (BD Diagnostic Systems) containing medium selective for mycobacteria; the slants were incubated for up to 2 months. The bacterial suspensions that grew from any MGIT tubes were streaked onto L-J slants. The colonies that grew on the L-J slants were collected and further examined with an AccuProbe test (Gen-Probe) specific for Mycobacterium tuberculosis (Sloutsky et al., 2004) as well as with standard biochemical methods for identifying NTM (Witebsky & Kruczak-Filipov, 1996) .
In addition, because three RCWs in hospitals B, C and D in central Taiwan reported having nosocomial mycobacterial outbreaks between 2004 and 2005 , two AFB-positive clinical isolates were also obtained from each of these RCWs and examined.
Environmental mycobacterial isolates. At the time of collection of the transbronchial aspirates from the enrolled patients, three repeated isolations of environmental mycobacterial specimens were performed. Isolation of mycobacteria from each of two sources of tap water and the one drinking water machine in the RCWs in hospitals A and B was performed according to the method of Falkinham et al. (2001) . Briefly, 300 ml water samples were centrifuged (5000 g for 20 min at 25 uC). The pelleted cells were suspended in 1 ml sterile distilled water, and 0.1 ml samples were spread on the surface of Middlebrook 7H10 agar medium (BBL Microbiology Systems) containing 0.5 % (v/v) glycerol and 10 % oleic acid/albumin enrichment. Sodium thiosulfate was used to neutralize free disinfectant in the tap water, cetylpyridinium chloride was used to kill non-mycobacterial microorganisms and the specimens were plated on Middlebrook 7H10 agar plates. The plates were incubated at 37 uC with 5 % CO 2 for 2 months. Middlebrook 7H10 agar plates were placed beside the patients for detection of organisms in the room. Swabs for culture were also taken from the ventilator and other inanimate surfaces. Mycobacterial colonies were identified by AFB staining, standard biochemical methods and sequencing of the 16S rRNA gene (Goldblatt & Ribes, 2002; Kirschner et al., 1992) .
Heat-shock protein 65 encoding gene (hsp65) PCR-RFLP analysis. Mycobacterial strains were classified into subtypes on the basis of the restriction patterns of the Telenti fragment (441 bp) from the gene encoding the 65 kDa heat-shock protein (Hsp65) during analysis by RFLP (Brunello et al., 2001) . Mycobacterial genomic DNA was extracted using the cetyltetramethyl ammonium bromide method recommended by Ollar & Connell (1999) . The PCR was performed with primer pairs Tb11 (59-ACCAACGATGGTGTGTCCAT-39) and Tb12 (59-CTTGTCGAACCGCATACCCT-39) according to the method of Telenti et al. (1993) under the following conditions: 1 cycle at 95 uC for 5 min; 35 cycles at 95 uC for 1 min, 58 uC for 1 min and 72 uC for 1 min: and a final extension step at 72 uC for 10 min. The PCR products were analysed by 2 % agarose gel electrophoresis.
For restriction fragment analysis, 20 ml PCR product was digested with BstEII or HaeIII. The reaction mixture was analysed by 6 % PAGE and visualized by ethidium bromide staining under UV irradiation (Gaafar et al., 2003; Taillard et al., 2003; Zhang et al., 2004a) . A DNA ladder (20 bp marker; Bertec) was used as a size marker. Subtype assignments were made on the basis of polymorphisms in the length of the PCR restriction fragments according to the PRASITE Identification of Mycobacteria website (http://app.chuv.ch/ prasite/index.html).
PFGE. Analysis of large restriction fragment profiles by PFGE was performed by a modification of the methods of Wallace et al. (1993) and Sperner et al. (1999) . Briefly, isolates of M. abscessus were cultured for 3-5 days at 37 uC in L-J medium. The bacteria were collected and resuspended in SEM buffer (75 mM NaCl, 25 mM EDTA) and the bacterial concentration was adjusted to an OD 600 of 1.6. Cell suspensions were mixed in a 1 : 1 ratio with 1 % SeaKem Gold agarose (Cambrex) and pipetted into disposable plug moulds (Bio-Rad). The plugs were lysed with 20 ml lysozyme (20 mg ml
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; Sigma-Aldrich) and 20 ml lysostaphin (500 mg ml
; Sigma-Aldrich) and incubated at 37 uC for 2 h. The lysis solution was replaced with 2 ml cell lysis buffer [50 mM Tris/HCl (pH 8.0), 50 mM EDTA, 1 % sarcosine] and 20 ml proteinase K (20 mg ml
; Sigma) and incubated at 56 uC for 2 h with shaking (160 r.p.m.). The plugs were washed twice with ddH 2 O in a shaking water bath at 56 uC for 15 min each and then four times with Tris (10 mM)/EDTA (1 mM) buffer (pH 8) for 15 min each.
The plugs containing the genomic DNA were placed into 200 ml solution containing 20 U DraI (New England Biolabs) and incubated at 37 uC for 4 h, washed with 200 ml Tris (10 mM)/EDTA (1 mM) buffer (pH 8) and embedded in 1 % SeaKem Gold agarose gel. PFGE was carried out on a CHEF DRIII apparatus (Bio-Rad) at 14 uC for 20 h in 0.56 TBE buffer [1 M Tris/HCl (pH 8), 0.9 M boric acid, 10 mM Na 2 EDTA] with or without 100 mM thiourea (Zhang et al., 2004b) at 200 V. The pulse time was ramped from 20 to 40 s for 14 h and from 150 to 180 s for 6 h over a total run time of 20 h. The gel photographs were then scanned and analysed using Bionumerics software version 3.3 (Bio-Image Systems). Genomic DNA from Salmonella enterica serovar Braenderup H9812 (Chang et al., 2005) and Staphylococcus aureus NCTC 8325 (Singh et al., 1999) were used as DNA size standards. DNA bands were visualized by ethidium bromide staining under UV light and photographed.
PFGE pattern analysis. PFGE patterns were analysed by computerized band analysis with Bionumerics software version 3.3 and classified on the basis of the criteria of Luna et al. (2000) . When a pattern differed from the others by four or more bands, the pattern was designated a main type or cluster and given a name with the first letter of the restriction enzyme and an assigned number (e.g. D1-D10 for DraI). When there were three or fewer band differences, the PFGE patterns were designated subtypes and given a subscripted number (e.g. D1 1 , D1 2 ). The subscript 1 indicated one band added to the pattern, whereas a subscript followed by a letter in parentheses [e.g.
D1 1(A)
] denoted the addition of one different band to the pattern. Likewise, the subscript 2 (e.g. D1 2 ) indicated that one band was deleted from the pattern; the subscript 3 (e.g. D1 3 ) indicated that two bands were different and the subscript 4 (e.g. D1 4 ) indicated that three bands were different from the main pattern. Isolates that had identical or related (with three or fewer band differences) DraI patterns during PFGE were considered to be genetically related, whereas isolates with four or more different bands were considered to be genetically unrelated. To avoid confusion, the patterns from environmental mycobacterial isolates were named with the letter E and an assigned number (e.g. E1) and the standard M. abscessus ATCC 19977 strain was classified as S1.
Cluster analysis was carried out and a dendrogram was constructed using the UPGMA. A band position tolerance of 2 % was used to compare fingerprint patterns.
Statistical analysis. Means±SD or frequency (%) were calculated for each subtype and analysed. Wilcoxon's rank-sum test or Fisher's exact test were used to compare the co-morbidities and clinical outcomes of the initial patients from whom M. abscessus type I was isolated with those from whom M. abscessus type II was isolated. Data were analysed with SAS 9.0 (SAS Institute). A value of P,0.05 was considered statistically significant.
RESULTS

Enrolled patients and clinical isolates
From May 2004 to March 2005, the medical records of the 43 patients in the 39-bed RCW of hospital A were reviewed. All patients were dependent on ventilators, and had chronic respiratory symptoms and abnormalities observed on chest radiographs. Among the 38 initial patients enrolled before 15 May 2004, 23 had AFB in smears and mycobacterial growth in cultures from at least three transbronchial aspirates, whilst 5 had AFB in smears and mycobacterial growth in cultures from two transbronchial aspirates (Table 1) . Cultures of all of these specimens grew organisms that were identified as M. abscessus. Fifteen of the twentyeight initial patients who had AFB in their smear samples and mycobacterial growth in cultures from at least two transbronchial aspirates had disease progression observed by serial chest radiography and were symptomatic. Therefore, there were 15 initial patients who met the ATS criteria for M. abscessus pulmonary disease. Among the remaining ten patients, one had AFB and mycobacterial growth from the culture of one transbronchial aspirate. Another initial patient had negative smear results for AFB in three transbronchial aspirates but had mycobacterial growth from the culture of one transbronchial aspirate. The cultured specimens from these two patients were also identified as M. abscessus. The first clinical isolate obtained from culture of the transbronchial aspirate specimens from each of these 30 patients was collected for further study; thus, a total of 30 independent clinical isolates was obtained. Transbronchial aspirate specimens from the remaining eight patients grew no mycobacteria (Table 1) .
Among the five newly admitted patients in the RCW of hospital A (admitted between 15 May 2004 and March 2005) , all had AFB in the smear and mycobacterial growth in the culture from one transbronchial aspirate. The cultured specimens from these five newly admitted patients were also identified as M. abscessus (Table 1) . Two clinical isolates obtained from each of hospitals B, C and D were also identified as M. abscessus (data not shown).
Epidemiology assessment
The epidemiological curve describing the infections in hospital A is shown in 
Isolation of mycobacteria from environmental water sources (environmental isolates)
One of the two tap water samples collected from the RCW of hospital A grew mycobacterial colonies on Middlebrook 7H10 plates. The colonies were examined, and two strains were observed that were identified as Mycobacterium mucogenicum and Mycobacterium senegalense. The other water sample produced no growth of mycobacteria. Two tap water samples from the RCW of hospital B were collected, and M. abscessus was identified in both samples. No mycobacterial colony growth was found in the specimens from the drinking water machines, room ventilation or inanimate surfaces in the RCWs of hospitals A and B.
hsp65 PCR-RFLP analysis A total of 39 isolates from the 4 hospitals were processed. In hospital A, two clinical strains isolated from the initial patients were not available for hsp65 PCR-RFLP analysis (they had been lost 
PFGE analysis
The clinical isolate from one initial patient was lost during PFGE pattern analysis. PFGE profiles were analysed for a total of 38 clinical strains and 4 environmental strains isolated from the 4 RCWs. PFGE after DraI digestion of chromosomal DNA revealed 10-16 fragments ranging from 54 to 664 kb, and 10 distinct cluster patterns among the clinical strains from hospitals A, B, C and D were identified (Fig. 2) . The clinical strains isolated from hospital A could be grouped into nine different PFGE clusters. The largest cluster, D1 (a total of 14 isolates), contained six indistinguishable clinical strains, four with one band difference [D1 1 and D1 1(A) ] and four with three band differences (D1 4 ). MRG1, the isolate from the first patient who presented with symptoms during the study, and MRG4, the isolate from a patient in the adjacent bed, were in the D1 cluster. The cluster D2 contained seven clinical isolates, including one unique clinical strain (D2) and six strains with two band differences [D2 3 and D2 3(A) ]. MRG2, the isolate from the other patient adjacent to the first patient, was also in the D2 cluster. The D7 cluster contained five identical clinical isolates, including two isolates (MRG24 and MRG26) from initial patients and one isolate (MRG52) from a newly admitted patient. Two clinical strains from hospital B (CHIN-CHEN1 and CHIN-CHEN2) belonged to the D7 cluster and were identical to those in hospital A. Two clinical strains in hospital C, designated D10, were different from those seen in hospitals A and B but indistinguishable from the two clinical strains in hospital D. In hospital A, one environmental strain belonged to the E1 cluster; and the other environmental strain belonged to the E2 cluster. In hospital B, one environmental strain (CHIN-CHEN20) belonged to the D7 cluster; and the other environmental strain (CHIN-CHEN15) belonged to the D1 cluster (Fig. 2) .
Of six clinical isolates from the four hospitals that were identified as M. abscessus type I (strain: MRG3, MRG17, MRG24, MRG26, MRG27 and CHIN-CHEN1), three (MRG24, MRG26 and CHIN-CHEN1) produced smear patterns when PFGE was performed without thiourea; these had clear PFGE profiles after thiourea was added to the running buffer, and were indistinguishable and belonged to the D7 cluster (data not shown).
Clinical isolates, hsp65 RFLP types and PFGE patterns in hospital A
The largest clusters of D1 and D2 were identified as M. abscessus type II. The D4 3 , D6, D7, D5 and D8 clusters were found to be M. abscessus type I. The clinical isolates of the D1 cluster were distributed widely throughout the RCW, whereas the clinical isolates of the D2 cluster were frequently isolated from one of the three areas in the RCW. Among the strains isolated from the five newly admitted patients, three (MRG51, MRG72 and MRG74) showed D1 patterns (similar to those in the initial patients with strains belonging to the D1 cluster), one (MRG52) belonged to the D7 cluster and one (MRG75) belonged to the D9 cluster.
Clinical outcomes after 1 year
The characteristics and outcomes of the 28 initial patients who had AFB in smears and mycobacterial growth in cultures from at least two transbronchial aspirates were analysed according to whether they were infected with M. abscessus type I or type II, as determined by the hsp65 PCR-RFLP results (Table 2) . Only 15 patients with disease progression as determined by chest radiography met the ATS criteria for M. abscessus pulmonary disease. Five patients with type I and six with type II received at least 1 month of a drug regimen that included macrolides. There was no statistically significant difference in age, sex or co-morbidities between the patients infected with the two types. The rate of mortality appeared to be higher in the patients infected with M. abscessus type I, although this difference did not reach statistical significance. However, the proportion whose disease progressed, as determined by chest radiography, was significantly higher in the patients infected with M. abscessus type I (P50.0441; Table 2 ). M. abscessus is a rapidly growing NTM species. Nosocomial transmission of this organism can result in a variety of conditions, ranging from surgical wound infections after facial and breast plastic surgery or cardiac surgery to invasive infections such as chronic pulmonary disease (Fox et al., 2004; Koh et al., 2002; Phillips & von Reyn, 2001; Scholze et al., 2005) . Since the mid-1970s, the frequency of reported outbreaks in healthcare settings caused by this species has increased (Phillips & von Reyn, 2001 ). However, M. abscessus outbreaks have rarely been reported in patients who are chronically dependent on ventilators.
Because M. abscessus is widely distributed in the environment and frequently recovered from water, soil, food and animals, contamination of clinical specimens can occur, resulting in a so-called pseudo-outbreak. Therefore, the diagnosis of NTM lung disease is only made in cases that conform to strict diagnostic criteria including positive results produced in multiple specimens (Griffith et al., 2007) . The cases of 15 of the patients described in this report fulfilled these criteria; therefore, we concluded that true infections were present among these patients in hospital A.
We attempted to identify the sources of the infections by molecular typing of the clinical and environmental isolates. At least one report has described the colonization of patients' respiratory tracts resulting from NTM in the hospital's water supply (Burns et al., 1991) , and M. abscessus is commonly found in hospital water supplies (Wallace et al., 1998 ). Therefore, we tested two water sources in the RCWs along with the clinical isolates. The results of analysis by PCR-RFLP showed that all of the clinical isolates belonged to types I (from hospitals A and B) and II (from hospitals A, C and D) as determined by the restriction pattern of the 441 bp Telenti fragment of the hsp65 gene sequence (Devallois et al., 1997) . PFGE after restriction with DraI revealed that the clinical isolates comprised ten clusters. Nine of these clusters (D1-D9) were found in hospital A, one of the nine found in hospital A was also found in hospital B (D7), and the tenth (D10) was found only in hospitals C and D. In hospital B, both environmental isolates were M. abscessus, and at least one environmental isolate (CHIN-CHEN20) belonged to the same cluster as the two clinical specimens (CHIN-CHEN1 and CHIN-CHEN2). The tap water sources, therefore, seemed to be the source of transmission in hospital B. However, in hospital A, both environmental strains belonged to different species of mycobacteria (clusters E1 and E2) that did not appear in any of the clinical isolates or any isolates from the other hospitals. This result and the observed genetic diversity of the isolates from the patients in hospital A indicated that contamination from the tap water sources was not responsible for the positive clinical specimens and suggested that the patients became infected through contact with multiple other environmental sources or other patients. No instruments were used routinely among the patients in the RCW that could be identified as probable sources of transmission. No mycobacterial colony was found in specimens from drinking water machines, room ventilation or inanimate surfaces. None of the initial patients or newly admitted patients had wounds or surgical sites. Therefore, we speculated that contact with other patients was the probable source of transmission.
As noted above, M. abscessus outbreaks have rarely been reported in patients who are chronically dependent on ventilators. Therefore, our findings that most of the patients in the RCW of hospital A were infected and that the clinical isolates belonged to a variety of unrelated clusters were contrary to our expectation that the source of the infections would be environmental and that a single clone would be isolated from a only few patients. These findings raise two important questions: first, whether all of the patients had clinically significant pulmonary disease caused by M. abscessus, as opposed to airway colonization; and secondly, whether there was a high level of polyclonal yet 'silent' endemic infections over a period of time, of which we were unaware. The ATS states that not enough is known about the pathophysiology of NTM lung disease to be sure that colonization is not, in fact, an indolent or slowly progressive infection (Griffith et al., 2007) . Symptoms were present in the patient whose case caused us to initiate the surveillance programme, and 15 of the patients showed signs of disease progression on chest radiography. Therefore, we assumed that, at least among the 15 patients whose diagnoses were confirmed according to the ATS criteria, clinically significant disease was present. We cannot prove whether or not the infections observed in this study represented a polyclonal outbreak or a high level of endemic infections with different clones; however, the number of distinct types and clusters of M. abscessus suggests that the latter may have been the case.
We noticed that the isolates from the two patients from hospital B belonged to the D7 cluster, which also contained three clinical strains isolated from patients in hospital A. Furthermore, the isolates from hospitals C and D were identical. This suggested the possibility that these strains could have been acquired by patients who moved back and forth between the RCWs of these hospitals. In Taiwan, RCWs are long-term chronic care facilities that have been developed for managing patients with chronic ventilator dependency. The IDS that was initiated by the Bureau of National Health Insurance in Taiwan (Lin & Zhao, 2002) offers clinical integration of such patients within three types of step-down units: the intensive care unit (ICU), the respiratory care centre (RCC), a step-down unit of the ICU, and the RCW, a step-down unit of the RCC. These units are integrated both vertically and horizontally (Fig. 3) . Therefore, stable patients in one hospital's RCW might be transported to another hospital's RCW (horizontal integration). Similarly, if the clinical condition of a patient in an RCW deteriorates, the patient could be transferred to the ICU of the same or a different hospital (vertical integration). If the patient's condition improves, the patient could be transferred back to the RCC and RCW. Unfortunately, this system could facilitate the spread of nosocomial mycobacterial infections between hospitals if diagnosis is delayed, as is often the case with mycobacterial infection.
We found that the rate of disease progression , as determined by chest radiography, was significantly higher in patients with M. abscessus type I isolates than in patients infected with M. abscessus type II. Furthermore, there was a slightly higher rate of mortality among these patients. This could indicate that type I is a more virulent form. Molecular typing of clinical isolates from Mycobacterium kansasii has shown differences in the pathogenicity among several subtypes (Taillard et al., 2003) . However, the clinical significance of the two types of M. abscessus found in the clinical isolates from our investigation is unclear; additional studies will be needed to confirm these preliminary results.
Several limitations of this study should be noted. We were not able to undertake sequencing of multiple loci within the isolates. Therefore, we could not differentiate M. abscessus from Mycobacterium massiliense and Mycobacterium bolletii using the methods reported recently by Zelazny et al. (2009) . The size of the cohort of patients in this study was small, and we do not have data to confirm which of the patients in this study were indeed moved between wards or hospitals during the study period. A case-control study is currently underway to investigate further whether the movement of patients among wards and hospitals within the IDS is a factor in the spread of M. abscessus infections. Fig. 3 . Outline of the IDS for patients with chronic ventilator dependency in Taiwan. This system offers clinical integration of such patients within three types of step-down unit: the ICU, the RCC and the RCW. These units are both vertically and horizontally integrated according to the patient's clinical condition.
Conclusions
Fifteen of thirty-eight patients in a long-term RCW for patients with chronic ventilator dependency were found to have pulmonary infections with M. abscessus in a single hospital in 2004. Molecular typing of clinical isolates from these and five additional patients who entered the ward after the start of the study revealed that the isolates belonged to nine clusters and comprised types I and II. Clinical and environmental isolates from one other hospital that had an outbreak were similar to several of the isolates from hospital A, and isolates from two other hospitals were similar to each other. Further studies are needed to determine whether these infections may have been acquired by patients who moved back and forth among these hospitals, a routine practice in Taiwan's IDS for patients with chronic ventilatory dependency.
